EP0745401A2 — Inhaler type medicine administering device
Assigned to Dott Co Ltd · Expires 1996-12-04 · 29y expired
What this patent protects
An inhaler type medicine administering device comprises a generally cylindrical inhaling piece including a holder accommodating section located at one side of the inhaling piece, and an inhaling mouth located at the other side of the inhaling piece. A generally cylindrical capsul…
USPTO Abstract
An inhaler type medicine administering device comprises a generally cylindrical inhaling piece including a holder accommodating section located at one side of the inhaling piece, and an inhaling mouth located at the other side of the inhaling piece. A generally cylindrical capsule holder is disposed in the holder accommodating section and formed with a capsule accommodating hole which opens at one end of the capsule holder. A capsule is to be disposed in the capsule accommodating hole. First and second pin insertion holes are formed in the capsule holder and the inhaling piece and respectively located to be connected with axially opposite sections of the capsule accommodating hole. Each pin insertion hole extends generally in a diametrical direction of the inhaling piece and the capsule holder. An air flow passage is axially formed at at least one of an inner peripheral surface of the inhaling piece and an outer peripheral surface of the capsule holder. The first and second pin insertion holes are communicated with each other through the air flow passage. Additionally, a perforator is provided having first and second pins which are to be inserted respectively into the first and second pin insertion holes to form holes in the capsule which holes are in communication with the air flow passage.
Drugs covered by this patent
- Arnuity Ellipta (FLUTICASONE FUROATE) · Haleon Us Holdings
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.